Skip to content
Recall Observatory FDA recall evidence

Drug product

Lisinopril and Hydrochlorothiazide Tablets USP, 20 mg/12.5 mg, 500-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, INDIA, NDC 68180-519-02

D-1581-2019

July 19, 2019

Class II

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 83363
Status
Terminated
Classification
Class II
Quantity
11,832 bottles
Official record key
drug-enforcement:D-1581-2019

Official wording

Reason: Presence of Foreign Tablets/Capsules: Product complaint received of one Fenofibrate tablet 145mg observed in 500 s count product bottle.

Code information: Lot #:H801815, Exp. March 2021

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Foreign Tablets